⌘K
Loading ticker…
As of 2026-08-25, Syndax Pharmaceuticals, Inc. (SNDX) has a 3-month relative strength percentile of 49 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 51. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.1%, relative volume 0.70×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
SNDX is held by 23 ETFs as of May 2026. Top owner: VTWO at 0.05% weight, $9M notional. Top 3 carry $22M.
Held by 52 ETFs · $280M across latest filings · largest weight 1.68% (BBP).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.05% | $9M | −0.01 pp |
| SCHASchwab U.S. Small-Cap ETF | 0.04% | $8M | — |
| VHTVanguard Health Care ETF | 0.03% | $5M | — |
| VFMO | 0.11% | $2M | +0.04 pp |
| VTWG | 0.09% | $1M | −0.02 pp |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.80% |
| $1M |
| −0.93 pp |
| DWAS | 0.26% | $1M | new |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $1M | — |
| ONEQ | 0.01% | $554K | — |
| ISMD | 0.14% | $451K | −0.05 pp |
Showing 10 of 23 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SNDX Jan avg: 2.86% median: 1.93% win: 50% σ: 8.56% n: 4 2022-04-12 → 2026-07-31 | SNDX Feb avg: 5.00% median: 8.63% win: 75% σ: 11.53% n: 4 2022-04-12 → 2026-07-31 | SNDX Mar avg: -7.25% median: -7.58% win: 50% σ: 14.01% n: 4 2022-04-12 → 2026-07-31 | SNDX Apr avg: -2.46% median: -5.31% win: 20% σ: 10.37% n: 5 2022-04-12 → 2026-07-31 | SNDX May avg: -9.47% median: -8.59% win: 0% σ: 9.55% n: 5 2022-04-12 → 2026-07-31 | SNDX Jun avg: 5.68% median: 6.54% win: 80% σ: 10.48% n: 5 2022-04-12 → 2026-07-31 | SNDX Jul avg: 2.28% median: 5.87% win: 80% σ: 9.00% n: 5 2022-04-12 → 2026-07-31 | SNDX Aug avg: 14.47% median: 3.22% win: 50% σ: 35.84% n: 4 2022-04-12 → 2026-07-31 (current) | SNDX Sep avg: -7.97% median: -6.06% win: 25% σ: 9.78% n: 4 2022-04-12 → 2026-07-31 | SNDX Oct avg: -5.12% median: -3.74% win: 0% σ: 4.02% n: 4 2022-04-12 → 2026-07-31 | SNDX Nov avg: 13.97% median: 11.29% win: 75% σ: 23.76% n: 4 2022-04-12 → 2026-07-31 | SNDX Dec avg: 5.28% median: 6.11% win: 75% σ: 20.75% n: 4 2022-04-12 → 2026-07-31 |